|
Kenton Shultis has 20 years of industrial experience with Abbott Laboratories, Merck & Co., and Bristol-Myers Squibb. He received his Master's degree from the University of Minnesota under Prof. K. H. Keller and his B.S.Ch.E. from the University of Wisconsin. During his career, he has worked to bring nine major new drugs to market, and was responsible for the manufacture of Butorphanol and intermediates for Amikacin and TAXOL. At Bristol-Myers Squibb, he led the design, construction, and startup of three new pilot plants. Kenton has received multiple patents. | 